Literature DB >> 11767924

Secondary hypoparathyroidism attributed to hypomagnesemia in a dog with protein-losing enteropathy.

W W Bush1, S E Kimmel, M A Wosar, M W Jackson.   

Abstract

Severe hypomagnesemia (0.8 mg/dl; reference range, 1.6 to 2.3 mg/dl), hypocalcemia, and protein-losing enteropathy were identified in a 5-year-old castrated male 3-kg (6.6 lb) Shih Tzu examined because of anorexia, lethargy, paresis, and abdominal distention. Histologic examination of intestinal biopsy specimens revealed lymphangiectasia and lymphocytic, plasmacytic, neutrophilic infiltrates. Initial treatment included administration of magnesium (0.80 mEq/kg [0.36 mEq/lb]) of body weight in a balanced electrolyte solution. This treatment resulted in normalization of the serum magnesium concentration (1.7 mg/dl); resolution of the lethargy, paresis, and tachycardia; and an increase in the serum parathyroid hormone and ionized calcium concentrations. Findings were consistent with secondary hypoparathyroidism attributable to hypomagnesemia. Magnesium concentration should be monitored in all dogs with gastrointestinal tract disease, especially those with protein-losing enteropathy, anorexia, and weakness.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11767924     DOI: 10.2460/javma.2001.219.1732

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  6 in total

1.  Hypovitaminosis D is associated with negative outcome in dogs with protein losing enteropathy: a retrospective study of 43 cases.

Authors:  K Allenspach; J Rizzo; A E Jergens; Y M Chang
Journal:  BMC Vet Res       Date:  2017-04-08       Impact factor: 2.741

2.  Applicability of 99m Tc-Labeled Human Serum Albumin Scintigraphy in Dogs With Protein-Losing Enteropathy.

Authors:  N Engelmann; N Ondreka; K von Pückler; S Mohrs; J Sicken; R Neiger
Journal:  J Vet Intern Med       Date:  2017-02-21       Impact factor: 3.333

3.  2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1- Defining populations at risk.

Authors:  Armelle deLaforcade; Lenore Bacek; Marie-Claude Blais; Corrin Boyd; Benjamin M Brainard; Daniel L Chan; Stefano Cortellini; Robert Goggs; Guillaume L Hoareau; Amy Koenigshof; Ron Li; Alex Lynch; Alan Ralph; Elizabeth Rozanski; Claire R Sharp
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2022-05-02

4.  Clinical features, intestinal histopathology, and outcome in protein-losing enteropathy in Yorkshire Terrier dogs.

Authors:  S M Simmerson; P J Armstrong; A Wünschmann; C R Jessen; L J Crews; R J Washabau
Journal:  J Vet Intern Med       Date:  2014-01-27       Impact factor: 3.333

5.  Decreased serum zinc concentration in dogs with lymphocytic-plasmacytic enteritis, and its associations with disease severity and prognosis.

Authors:  Kosei Sakai; Shingo Hatoya; Masaru Furuya; Shunsuke Shimamura; Tomoyo Nabetani; Hiroyuki Tani; Terumasa Shimada
Journal:  J Vet Med Sci       Date:  2020-04-16       Impact factor: 1.267

6.  Clinical features of muscle cramp in 14 dogs.

Authors:  Teresa Gagliardo; Roberta Ruggeri; Andrea Di Paola; Massimo Baroni; Giunio B Cherubini; Antonella Gallucci; Cristian Falzone; Stefania Trimboli; Andrey Albul; Gualtiero Gandini
Journal:  J Vet Intern Med       Date:  2020-11-28       Impact factor: 3.175

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.